NAD+ is required to support tumor growth, both as substrate for PARP [91] and for function of SIRT1, an NAD+ dependent deacetylase whose activity is associated with deacetylation of p53, consequently leading to progressive tumor growth [93]. This evidence concerns the gene SIRT1 and neoplasm.